Re: FDA approves Pfizer nerve pain drug ~ Lyrica
From: Sharon Hope (shope_at_anet.net)
Date: 01/05/05
- Next message: Sharon Hope: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Previous message: Sharon Hope: "Re: FDA: 139,000 people had heart attacks that may be linked to Vioxx"
- In reply to: listener: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Next in thread: Don Kirkman: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Messages sorted by: [ date ] [ thread ]
Date: Wed, 05 Jan 2005 03:05:19 GMT
Don confused her teaching at USC and UCSD and her NIH statin study with her
practice.
Her practice is at the VA.
As for the rest of her CV, I think her accomplishments are worthy of
admiration and deserve notice.
"listener" <listener@nospam.net> wrote in message
news:Xns95D4622098E03some1outthere@38.144.126.109...
> Where is Don questioning Dr. Golomb's credentials? I missed that. And
> ehat do *her* credentials have to do with *your* statements?
>
> This semms like just another non-response response, which you and zee are
> very good at. It's just like a shell game: throw out erroneous or bogus
> "facts" (which, of course, you're free to do) and when questioned on
> them, divert attention.
>
>
> L
>
>
> "Sharon Hope" <shope@anet.net> wrote in
> news:qinCd.745407$mD.158002@attbi_s02:
>
>> You are ignorant of the facts in this case.
>>
>> Dr. Golomb does not practice at the university. Her practice is at
>> the VA Medical Center.
>>
>> A renaissance woman, she is the NIH Principal Investigator for the NIH
>> Statin Study (which accepts no drug company funding), and concurrently
>> she is teaching at two universities, and a RAND researcher. She is
>> also the US DOD's expert on Gulf War Syndrome.
>>
>> Her credentials are readily accessible (CV below). What are your
>> credentials?
>>
>> Her CV:
>> http://medicine.ucsd.edu/faculty/golomb/
>>
>> CURRICULUM VITAE
>> Beatrice Alexandra Golomb, MD, PhD
>> CURRENT POSITIONS
>>
>> a.. Assistant Professor of Medicine, U.C. San Diego April 1998-
>> Division of General Internal Medicine
>>
>>
>> b.. Staff Physician, San Diego VA Medical Center Aug 1, 1996 -
>> Division of General Internal Medicine
>> 3350 La Jolla Village Dr.
>> San Diego, CA 92161
>>
>>
>> c.. Research Associate Professor, Dept. of Psychology, USC: Oct
>> 1998- Social Science Research Institute
>> University of Southern California
>> University Park Los Angeles, CA 90089-0375
>>
>>
>> d.. Health Consultant, RAND: Aug 1996 -
>> 1700 Main St.,
>> M-28 P.O. Box 2138
>> Santa Monica, CA 90408-2138
>> (310) 393-0411 x6606
>> EDUCATION AND TRAINING
>>
>> EDUCATION
>>
>> a.. BS, Physics, Summa Cum Laude, University of Southern California,
>> 1979
>>
>>
>> b.. Medical Scientist Training Program, University of California,
>> San
>> Diego, June, 1979
>>
>>
>> c.. PhD, Biology, University of California, San Diego, June, 1988
>>
>>
>> d.. MD, University of California, San Diego, June, 1989
>>
>>
>> e.. Postdoctoral Fellow, Computational Neurobiology Laboratory, Salk
>> Institute, 1989-1990
>>
>>
>> f.. Medical Resident, West Los Angeles V. A. Medical Center,
>> 1990-1993
>>
>>
>> g.. Chief Medical Resident, West Los Angeles V. A. Medical Center,
>> 1993-1994
>>
>>
>> h.. Robert Wood Johnson Clinical Scholar, UCLA, 1994-1996
>> MAJOR AREAS OF TRAINING
>>
>> a.. Physics (BS)
>> b.. Neurobiology (PhD)
>> c.. Neural Networks (Postdoctoral fellowship)
>> d.. Internal Medicine (MD, internship, residency, chief residency)
>> e.. Health Services Research & Research methodology (Robert Wood
>> Johnson
>> Clinical Scholarship)
>> Back to Top
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> LICENSURE: California, Issued 10-8-91
>>
>> BOARD CERTIFICATION
>>
>> Diplomate, American Board of Internal Medicine, September 1993
>>
>> Diplomate, American Board of Forensic Examiners
>>
>> Back to Top
>>
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> PROFESSIONAL ACTIVITIES AND AFFILIATIONS
>>
>> Member, Medical Science Training Program Student Advisory Committee,
>> UCSD School of Medicine, September, 1999-
>>
>> Associate Fellow, American Heart Association Council on Epidemiology
>> and Prevention, elected March 25, 1999
>>
>> Fellow, 23rd Annual 10-day Seminar on the Epidemiology and Prevention
>> of Cardiovascular Diseases, 1997
>>
>> Diplomate and member, American College of Forensic Examiners, 1996-
>>
>> Member, American College of Physicians, March 1995-
>>
>> Pharmacy and Therapeutics Committee, WLA VA Medical Center, 1993-1994
>>
>> Ethics Committee, West LA VA Medical Center, 1991-1994
>>
>>
>> Peer Reviewer in various journals including: JAMA, BMJ, Circulation, J
>> Clin Epi, Am J Med, Ann Behav Med, Psychosomatic Med, Psychiatric
>> Services, Am J Epi, Am J Primatology, Complex Systems, Evolutionary
>> Anthropology, J Gen Internal Med, & Medical Care
>>
>> Peer Review participation, Books: Oxford University Press
>>
>>
>> Back to Top
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> AWARDS AND HONORS
>>
>> a.. Who's Who in America, 2000
>> b.. Solomon Scholar Research Award, UCLA, 1993
>> c.. Solomon Scholar Research Award 1992
>> d.. Phi Kappa Phi, 1979
>> e.. Emma Josephine Bradley Bovard Award, 1979
>> f.. Junior Phi Beta Kappa, 1978
>>
>> Back to Top
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> RESEARCH GRANTS AND TOPICS OF INTEREST
>>
>> RESEARCH GRANTS
>>
>> Funded: NIH RO1
>>
>>
>> Project Title: Statins and Noncardiovascular Endpoints
>>
>> Project Number; 98-1060
>>
>> Amount (Total direct costs over 5 years) $4.1 million
>>
>> Dates: 8-1999 to 7-2004
>>
>> Principal Investigator: Beatrice A. Golomb
>>
>> Link to the UCSD Statin Study Website
>>
>> Funded: Harry Frank Guggenheim Foundation
>>
>> Project Title: Low Serum Cholesterol and Violent Behavior
>>
>> Amount: $30,000 per annum
>>
>> Dates: 1-1-96 to 1-1-98
>>
>> Principal Investigator: Beatrice A. Golomb
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> TOPICS OF INTEREST
>>
>> * Medical Reasoning (an abiding and unifying current interest, that
>> serves as the foundation for my interest in much of that below)
>>
>> * Illness in Persian Gulf War veterans (ongoing work for RAND funded
>> by the Department of Defense, book available on RAND's website; first
>> to synthesize information on Nerve Agent Pretreatment drug, "PB", with
>> neurobiological literature; concluded that a role cannot be excluded.
>>
>> * Lipids: work in UCSD Dept of Medicine. Currently am PI of a ~5
>> million dollar NIH study to evaluate noncardiovascular impact of lipid
>> reduction using statins; Work for RAND has included development of
>> quality-of-care indicators for hyperlipidemia.
>>
>> * Violence (work on link between lipids and violence; single-author
>> article in Annals of Internal Medicine synthesizing clinical work with
>> neurobiology; prompted a five-column article in the New York Times on
>> this work in March 1998). This work continues, partially at USC in
>> collaboration with Dr. Sarnoff Mednick; and with collaborators in
>> Scandinavia; I was PI of Guggenheim grant (at USC) examining relation
>> of lipids to violence.
>>
>> * Risk Benefit Assessment, with focus on restoring the risk to
>> risk-benefit. Fundamentally paradigm-shifting insights have been
>> presented at several talks, but not yet submitted for publication. I
>> have shown that randomized trials are performed in a way that is
>> inherently biased to demonstrate benefit and fail to show harm, if it
>> is present. Moreover, a much heralded "new paradigm" in which
>> cardiovascular disease risk is evaluated and used to determine
>> aggressiveness of preventive treatments (a paradigm utilized by
>> national guidelines for cholesterol and hypertension, among others)
>> provides a one-sided look: It notes that potential benefit varies from
>> individual to individual, and should be assessed (based on predictors
>> of cardiovascular disease) to guide aggressiveness of preventive
>> treatments. It implicitly (and improperly) assumes that treatment
>> risks, if any, are fixed and need not be formally assessed. To the
>> contrary, potential for harm also varies from individual to
>> individual, and can also often be estimated by examining risk factors
>> for adverse outcomes. Failure to consider treatment risks on par with
>> treatment benefits means some individuals will receive treatment
>> though potential harm exceeds benefit; while others may be denied
>> treatment though potential benefit exceeds harm.
>>
>> * Cardiovascular risk: work at UCSD in collaboration with Dr. Michael
>> Criqui, pertaining to lipids (and the preeminence of the total
>> cholesterol/HDL-cholesterol ratio as a predictor of cardiovascular
>> risk); alcohol and cardiovascular disease risk; peripheral artery
>> disease; and subclinical cardiovascular disease. Some of this work has
>> been cited in Cecil's Textbook of Internal Medicine, a preeminent
>> medical text. Work for RAND in this area has included development of
>> quality of care indicators for stroke, for men and for the frail
>> elderly (two distinct RAND projects).
>>
>> * Placebos: Methodologically vital observation published as a letter
>> to the Editor in Nature that the basis of "evidence-based" medicine,
>> the placebo controlled trial, rests on the assumption that placebos
>> are inert; but in fact there are no requirements about what goes into
>> them, their composition remains unpublished, and the drug companies
>> manufacturing the agent being tested typically determine the
>> composition. Moreover, there is no evidence that any agent is inert to
>> the degree required by recent very large clinical trials designed to
>> tap small effects; therefore, a positive, negative, or same direction
>> effect of a placebo can generate the spurious appearance of a
>> negative, positive, or null effect of the agent under scrutiny.
>> Moreover there are demonstrable cases of such problems arising in the
>> older literature, when placebo composition was actually sometimes
>> stated. Advised change in policy, at the minimum requiring placebo
>> composition to be stated in medical journals, and offered other
>> suggestions to mitigate the problem. Wrote a follow-up invited
>> Editorial in Chemistry and Biology.
>>
>> * Sex Recognition: Constructed the first neural network to identify
>> sex of a person from raw photographic images of their face; the
>> recognition task is difficult for humans when face is stripped of most
>> hair, makeup, and jewelry cues, and the "SexNet" actually did slightly
>> better than tested humans. This was the perhaps the first
>> demonstration that NNs could solve problems that, say, decision trees
>> could not solve - because we had no a priori concept of what features
>> were relevant, and permitted the network to figure this out. (We then
>> examined the hidden units to learn from the network.)
>>
>> * Facial Expressions (did the initial work on use of neural networks
>> in evaluating facial expressions; wrote the scientific part of NIH
>> grant proposal that funded continued work at the Salk in this area.)
>>
>> * Hiccups: Read the world's literature on this, my chosen topic for
>> the minor proposition exam for my PhD; can mount a good defense that I
>> am the world's expert in this topic. Wrote a draft of an opus on this
>> topic and have given medical lectures.
>>
>> * Foreign Body Munchausen's (identified the hitherto unrecognized link
>> between serial foreign body ingestion and the fabled Munchausen's
>> syndrome; manuscript in preparation.)
>>
>> * Visual perception and illusions (topic of PhD thesis): "Discovered"/
>> constructed two new visual illusions.
>>
>> Back to Top
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> PUBLICATIONS
>>
>> RESEARCH PAPERS
>>
>> Golomb BA, Stattin H, Mednick SA 2000. "Low cholesterol and violent
>> crime", J Psychiatric Res, in press.
>>
>> Golomb BA, Pyne JM, Wright B, Lohr JM, Bozzette SA 2000. "Primary care
>> for patients with severe mental illness: What role can psychiatrists
>> play?". Psychiatric Services, in press.
>>
>> Golomb BA, Criqui MH, Detrano RC, Wong ND, Bundens WP, Mattrey RF,
>> Denenberg JO 1999. "Noninvasive testing to detect subclinical
>> cardiovascular disease. What is its role?", Preventive Cardiology
>> 2(4):42-50 (Fall supplement).
>>
>> Golomb BA 1998. "Low cholesterol and violence: Is there a
>> connection?", Annals of Internal Medicine, 128:478-487.
>>
>> Criqui MH, Golomb BA 1998. "Epidemiologic aspects of lipid
>> abnormalities", American Journal of Medicine, 105 (1A): 48S-57S.
>>
>> Stewart-Bartlett M., Viola PA, Sejnowski TJ, Golomb BA, Larsen J,
>> Hager JC and Ekman P 1996 "Classifying facial action", Advances in
>> Neural Information Processing Systems 8: 823-829.
>>
>> Gray MS, Lawrence DT, Golomb BA and Sejnowski TJ 1995 "A perceptron
>> reveals the face of sex", Neural Computation, 7(6)1160-64.
>>
>> Golomb B, Lawrence DT, and Sejnowski TJ 1991, "SexNet: A neural
>> network that recognizes sex from human faces", Advances in Neural
>> Information Processing Systems 3, 572-577.
>>
>> Golomb B, Andersen RA, Nakayama K, MacLeod DIA, Wong A 1985, "Visual
>> thresholds for shearing motion in monkey and man", Vision Research 25,
>> 813-820.
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> EDITORIALS AND INVITED COMMENTARY
>>
>> Criqui MH and Golomb BA 1999 "Should patients with diabetes drink to
>> their health?", Journal of the American Medical Association 282
>> (3):279-80.
>>
>> Golomb B and Criqui M 1999 "Antihypertensives: Much Ado About Lipids",
>> Archives of Internal Medicine, 159: 535-537.
>>
>> Golomb B 1998 "Dietary Fats and Heart Disease: Dogma Challenged",
>> Journal of Clinical Epidemiology 51(6): 461-464.
>>
>> Golomb BA 1995 "Are Placebos Bearing False Witness?", Chemistry and
>> Industry 21: 900.
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> BOOKS
>>
>> Golomb BA 1999. "A Review of the Scientific Literature as it Pertains
>> to Gulf War Illnesses, Vol 2: Pyridostigmine Bromide". Washington, DC,
>> RAND (Has undergone external scientific peer review) Pp 1-385.
>>
>>
>> -----------------------------------------------------------------------
>> --------- TECHNICAL REPORTS AND RAND REPORTS
>> Golomb B 1999. Assessing the Care of Vulnerable Elders. Potential
>> Quality Indicators and Literature Review: Stroke. 113 pages.
>>
>> Perry W, Johnson D, Cecchine G, Golomb B, Hilborn L, Hearn A, Anthony
>> R 1999. Issues and Insights from the Army Medical Technology Workshop,
>> 1999. Prepared for the US Army Training and Doctrine Command and the
>> US Army Medical Department. PM-946-A, July 1999.
>>
>> Hilborne L and Golomb BA 2000. "A Review of the Scientific Literature
>> as it Pertains to Gulf War Illnesses, Vol 1: Infectious Diseases".
>> Washington, DC, RAND - in press.
>>
>> Golomb BA "Cerebrovascular disease", in Asch S, Kerr E, Geschwind S,
>> Clark K, Hamilton E, Heslin K, McGlynn EA (Eds.) Quality of Care for
>> Cardiopulmonary Conditions: A Review of the Literature and Quality
>> Indicators. RAND (Draft publication, Aug 1997): 42-62.
>>
>> Golomb BA "Chronic obstructive pulmonary disease", in Asch S, Kerr E,
>> Geschwind S, Clark K, Hamilton E, Heslin K, McGlynn EA (Eds.) Quality
>> of Care for Cardiopulmonary Conditions: A Review of the Literature and
>> Quality Indicators. RAND (Draft publication, Aug 1997): 63-87.
>>
>> Golomb BA "Hyperlipidemia", in Asch S, Kerr E, Geschwind S, Clark K,
>> Hamilton E, Heslin K, McGlynn EA (Eds.) Quality of Care for
>> Cardiopulmonary Conditions: A Review of the Literature and Quality
>> Indicators. RAND (Draft publication, Aug 1997): 169-185.
>>
>> Golomb BA "Peptic ulcer disease", in Asch S, Kerr E, Geschwind S,
>> Clark K, Hamilton E, Heslin K, McGlynn EA (Eds.) Quality of Care for
>> General Medical Conditions A Review of the Literature and Quality
>> Indicators. RAND (Draft publication, Sep 1997): 242-268.
>>
>> Hays RD, Vickrey BG, Golomb B "Health related quality of life measures
>> in studies of stroke", RAND, report to Pfizer, Inc., July 1997.
>>
>> Sherbourne CD, Golomb BA, Bystritsky A, Inkeles M, Marshall G "Summary
>> of Health-related Quality of Life Measures for Use in Anxiety
>> Disorders", RAND, report to Pfizer, Inc., July 1997.
>>
>> Gray MS, Lawrence DT, Golomb BA and Sejnowski TJ, (1993) "A perceptron
>> reveals the face of sex", Institute for Neural Computation Technical
>> Report Series, INC-9303.
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> BOOK CHAPTERS
>>
>> Golomb B. Health and Medical Factors: Cholesterol. In Encyclopedia of
>> Violence in the United States , Charles Scribner's Sons, 1999.
>>
>> Golomb B and Sejnowski TJ, "Sex recognition from faces using neural
>> networks". In: A. F. Murray (Ed.), Applications of Neural Networks,
>> Kluwer Academic Publishers 1995.
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> THESIS
>>
>> Golomb B 1988, "Visual Motion Processing: Some Special Properties",
>> PhD Thesis, Department of Biology, U. C. San Diego.
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> LETTERS TO THE EDITOR
>>
>> Golomb BA 1998 "Cholesterol and violence: Is there a connection".
>> Annals of Internal Medicine 129(8): 669-670.
>>
>> Golomb BA 1996 "Low serum cholesterol and serotonin metabolism --
>> other studies have been done in humans and monkeys. BMJ
>> 312(7041):1299.
>>
>> Golomb BA 1996 "Using placebos," Nature 379: 765.
>>
>> Golomb BA 1995 "Low cholesterol and violence," Arch Intern Med 155:
>> 2485.
>>
>> Golomb BA 1995, "Paradox of placebo effect," Nature 375: 530.
>>
>> Golomb B 1990, "Hiccup for hiccups," Nature 345: 774.
>>
>> Golomb B 1989, "Taking a byte out of time," JAMA 262: 3132.
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> BOOK REVIEWS
>>
>> Golomb BA 1997 "Catalyst -- For Change in Book Reviews", Chemistry and
>> Biology 4: 651-652.
>>
>> Golomb BA 1996 "Genius talk or moron babble? The complementarity
>> principle", Chemistry and Biology 3: 813-814.
>>
>> Golomb BA 1995 "Author's Imagination" (Review of Nature's Imagination:
>> The Frontiers of Scientific Vision) Chemistry and Biology 2(10):
>> 651-2.
>>
>> Back to Top
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> LECTURES, PRESENTATIONS & ABSTRACTS
>>
>>
>>
>> LECTURES & PRESENTATIONS
>>
>> "Medical Care: Restoring the Risk to Risk-Benefit Analysis".
>> University of Chicago Health Sciences group; Chicago, IL, Feb 8, 2000.
>>
>> "Gulf War Illness", VASDHS Medicine Faculty Development series, June
>> 11, 1999.
>>
>> "Aspirin for Primary Prevention of Coronary Artery Disease" Debate vs
>> Dr. Felicio. Dept of Medicine quarterly conference series, "Why Do We
>> Do It?", VA San Diego Healthcare System, Mar 26, 1999.
>>
>>
>> "Cholesterol and Violence: Where do we go from here?" Health Services
>> Research and Development Seminar Series, San Diego VAMC/UC San Diego,
>> Feb 11 1999.
>>
>> "Cholesterol and Violence", Colloquium, Social Science Research
>> Institute, USC, Los Angeles, CA, Nov 19, 1998.
>>
>> "Cholesterol and Violence", Grand Rounds, Dept of Psychiatry, UC San
>> Diego, La Jolla, CA, Nov 12, 1998.
>>
>> Invited speaker and panelist: "How might interdisciplinary models of
>> research guide us to a better understanding of violence?" USC
>> Interdisciplinary Perspectives for Understanding and Preventing
>> Violence, co-sponsored by the Violence Prevention Coalition of Greater
>> Los Angeles, Long Beach, CA, Apr 17, 1998.
>>
>> "Cholesterol and Violence", Dept of Psychology Colloquium, UCSD, San
>> Diego, Apr 16, 1998.
>>
>> "Measurement and Management of Hyperlipidemia for the Primary
>> Prevention of Coronary Heart Disease", with Dr. Michael H. Criqui.
>> Primary Care Grand Rounds, UCSD Dept of Family and Preventive
>> Medicine, San Diego, Apr 15, 1998
>>
>> "The Cholesterol Controversy", VA San Diego Healthcare System
>> quarterly "Why Do We Do It?" seminar, La Jolla, CA, Mar. 29, 1997.
>>
>> "Cholesterol and Violence: The Serotonin Connection", Mc Donnell Pew
>> Research Center, Warner Springs Ranch, CA, Mar. 15, 1997.
>>
>> "Cholesterol and Violence", USC Dept. of Preventive Medicine, Los
>> Angeles, CA, Feb 21, 1997.
>>
>> "The Cholesterol Controversy", San Diego VAMC, La Jolla, CA, Jan 10,
>> 1997.
>>
>> "Hyperlipidemia Panel Discussion" Discussants: Alistair Fyfe, MD, PhD;
>> B. Golomb, MD, PhD; David Heber, MD. UCLA Department of Medicine Grand
>> Rounds, Los Angeles, CA, Aug 14, 1996.
>>
>> "Cholesterol and Violence: Is There a Connection?" RAND/UCLA Child and
>> Adolescent Health Policy Seminar, RAND, Santa Monica, CA, July 9,
>> 1996.
>>
>> "Cholesterol and Violence: The Serotonin Connection", Telluride Summer
>> Research Center Public Lecture, Telluride, CO, July 5, 1996.
>>
>> "Cholesterol and Violence: New Evidence," UCLA Health Services
>> Research Seminar Series, Los Angeles, CA, June 21, 1996.
>>
>> "Cholesterol Reduction: When is it Indicated?" Cardiology Grand
>> Rounds, Cedars Sinai Medical Center, Los Angeles, CA, June 18, 1996.
>>
>> "Cholesterol, Serotonin, and Violence: Is there a Connection?," The
>> Helmholtz Society, UC Irvine, Irvine, CA, June 11, 1996.
>>
>> "Cholesterol Reduction in Primary Prevention: When is it Indicated?"
>> Cedars Sinai Medical Center, Health Services Research Group, Los
>> Angeles CA, Mar 6, 1996.
>>
>> "Cholesterol Reduction: When and Who?" St. Johns Medical Center, Santa
>> Monica, CA, Nov 2, 1995.
>>
>> "The Cholesterol Controversy": The Alzheimer Disease Research
>> Consortium of Southern California, USC, Los Angeles, CA, Apr 21, 1995.
>>
>> "Cholesterol Reduction in Primary Prevention": Debate vs Dr. David
>> Leaf. WLA VA Medical Center, Dept. of Medicine Grand Rounds, Mar 8,
>> 1995.
>>
>> "The Cholesterol Controversy," UCLA Dept. of Medicine Grand Rounds,
>> Jan 11, 1995.
>>
>> "Neural Networks Distinguish Demented Subjects from Elderly Controls
>> based on EEGs", Neural Information Processing Systems conference,
>> Neural Networks in Medicine workshop, Vail, CO, December 3, 1994.
>>
>> "Cholesterol Reduction in Primary Prevention: Rethinking the
>> Evidence," UCLA Dept. of Endocrinology Grand Rounds, September 21,
>> 1994.
>>
>> "Advance Directives", West Los Angeles VA Medical Center, Dept. of
>> Medicine Conference, September 16, 1994.
>>
>> "The Cholesterol Myth," Grand Rounds, West Los Angeles V. A. Medical
>> Center, Dept. of Medicine, June 8, 1994.
>>
>> "Death by Hiccup," Reno V. A. Medical Center, Dept. of Medicine
>> Conference, Reno Nevada, February 1994.
>>
>> "Hiccups," V. A. West Los Angeles Medical Center, Dept. of Medicine
>> Conference, January 1994.
>>
>> "Neural Networks that Recognize Sex and Expressions from Faces", in an
>> international conference, Facial Expression: Brain, Perception, and
>> Development, The Salk Institute, April 6, 1991.
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> ABSTRACTS
>>
>> Golomb, BA "Could dysregulation of acetylcholine (from pyridostigmine
>> bromide or other acetylcholinesterase inhibitors) contribute to
>> illness in Persian Gulf War veterans? Conference on Federally
>> Sponsored Gulf War Veterans' Illnesses Research, June 23-25, 1999
>> (Abstract accepted; withdrawn for security reasons at request of DoD)
>>
>> Golomb BA and Criqui MH 1998 "Put the risk back in risk-benefit", 1998
>> San Diego Biostatistics & Epidemiology Research Exchange Conference.
>> La Jolla, CA (Platform presentation 5-5-98.)
>>
>> Bagley S and Golomb BA 1998 "Patient interest and response to genetic
>> testing for cancer susceptibility: A systematic review of the
>> literature", American Federation for Medical Research, Western
>> Regional Meeting, Feb 4-7, Carmel, CA. J Investigative Medicine 46(1):
>>
>> Pyne J, Golomb B, Schten E, Jaworski B, Bozzette S 1998 "Appropriate
>> roles for psychiatrists delivering primary medical care", VA HSR&D
>> meeting, February 1998.
>>
>> Golomb BA 1996 "Low cholesterol and Violent Crime" Proceedings of the
>> Robert Wood Johnson Clinical Scholars Program 24th National Meeting,
>> Ft. Lauderdale, FL. (Platform presentation, Nov 1996.)
>>
>> Golomb BA 1995 "Cholesterol, serotonin, and violence: Is there a
>> connection?" Proceedings of the Robert Wood Johnson Clinical Scholars
>> Program 23rd National Meeting, Ft. Lauderdale, FL. (Platform
>> presentation, Nov 9, 1995.)
>>
>> Golomb B and Leuchter AF "Neural Networks Distinguish Demented
>> Patients from Elderly Controls Based on EEG Recordings" Solomon
>> Scholar Research Award, UCLA. (Platform presentation, June 1993.)
>>
>> Golomb B, Lawrence D, Sejnowski T, and Ekman P. "Neural Networks
>> Evaluate Facial Muscle Actions" Solomon Scholar Research Award, UCLA,
>> 1992. (Platform presentation, June 1992.)
>>
>> Golomb B 1990, "Cross adaptation to flow field motion", Investigative
>> Ophthalmology and Visual Science 31 (4):522. Poster presentation,
>> Association for Research in Vision and Ophthalmology, Sarasota, FL,
>> April 1989.
>>
>> Golomb B 1988, "Motion Escape", Investigative Ophthalmology and Visual
>> Science 29. Poster presentation, Association for Research in Vision
>> and Ophthalmology, Sarasota, FL, April 1988.
>>
>> Golomb B 1986, "The Crankshaft Effect", Investigative Ophthalmology
>> and Visual Science 27(3): 345. Poster presentation, Association for
>> Research in Vision and Ophthalmology, Sarasota, FL, April 1986.
>>
>> Golomb B, Andersen, RA, Nakayama, K, MacLeod, DIA, Wong, A. 1984
>> "Thresholds for shearing motion detection in monkey and man".
>> Investigative Ophthalmology and Visual Science 25(3):69. Poster
>> presentation, Association for Research in Vision and Ophthalmology,
>> Sarasota, FL, April 1984.
>>
>> Back to Top
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> BRIEFINGS AND EXPERT PANELS
>>
>>
>>
>> EXPERT PANEL PARTICIPATION
>>
>>
>> Panelist and speaker at event sponsored by the Violence Prevention
>> Coalition of Greater Los Angeles, entitled "How might
>> interdisciplinary models of research guide us to a better
>> understanding of violence?" 11-98
>>
>>
>> Expert panelist for NIH (NHLBI) Review Panel on "Prevention of
>> Cardiovascular Disease in Diabetes Mellitus: Clinical Center Network
>> Proposals"
>>
>>
>>
>> Expert "panelist" for the Department of Defense in the Army After Next
>> AMEDD Technical Workshop (aka "War Games") in MacLean,Virginia, to
>> help determine strategies for troop health protection (6-13 to 6-18,
>> 1999)
>>
>>
>>
>> Expert panelist for the Center for Health Policy Research/Health Care
>> Financing Association "Normative Standards Project", pertaining to
>> normative standards for home health care 6-99 (requested;
>> participation aborted due to date conflict with panel #3)
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> PRESENTATIONS BEFORE EXPERT PANELS
>>
>> 11-97: Briefings to Cardiopulmonary Expert Panel (panel of nationally
>> recognized experts): separate briefings on Stroke; Hyperlipidemia; and
>> COPD, toward development of quality of care indicators for these
>> conditions
>>
>> 10-97: Briefings to General Medicine Expert Panel (panel of nationally
>> recognized experts): briefing on Dyspepsia/Peptic Ulcer Disease,
>> toward development of quality of care indicators for these conditions
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> BRIEFINGS TO GOVERNMENT AGENCIES
>>
>> "Pyridostigmine Bromide: A Review of the Scientific Literature as it
>> Pertain to Gulf War Illnesses ", Testimony to Congress: House Veterans
>> Affairs Committee, Health Subcommittee and Benefits Subcommittee:
>> 11-19-99
>>
>> Briefings to members of Senate subcommittees (Foreign Affairs and
>> Veterans Affairs): 10-19-99
>>
>> "Pyridostigmine Bromide: A Review of the Scientific Literature as it
>> Pertain to Gulf War Illnesses ", Briefing to representatives of
>> multiple U.S. Veterans advocacy groups: 10-19-99
>>
>> "Pyridostigmine Bromide: A Review of the Scientific Literature as it
>> Pertain to Gulf War Illnesses ", Press Briefing from the Pentagon:
>> 10-19-99
>>
>> "Pyridostigmine bromide and illness in Persian Gulf War veterans"
>> Briefing to group consisting of: the Undersecretary of Health; the
>> Undersecretary of the Army; the Surgeon General of the Army; the
>> Principal Deputy for Health Affairs; representatives from the Surgeons
>> General of the Navy and Air Force; several other generals; and the
>> Directors of the Health and Defense Programs at RAND, in Washington
>> DC, on the effect of pyridostigmine bromide in illness in Gulf War
>> veterans. Feb 3, 1998, Washington DC. (The group convened for the
>> exclusive purpose of hearing my briefing.)
>>
>> "RAND on PB and Immunizations", Presidential Special Oversight Board
>> for Department of Defense Investigations of Gulf War Chemical and
>> Biological Incidents, Oct 28, 1998. Special Oversight Board Office,
>> Arlington VA.
>>
>> "RAND Center for Military Health Policy Research: Gulf War Illness"
>> (with Dr. Ross Anthony). Briefing to Major General James B. Peake,
>> Commanding General/Commandant/ Installation Commander, US Army Medical
>> Department Center and School. Oct 22, 1998. RAND Arroyo Center, Army
>> Research Division, Santa Monica.
>>
>> "Health Effects of Service in the Gulf War". Briefing to DARPA and DSO
>> (Defense Science Office), (with Dr. Ross Anthony). Sept 8, 1998,
>> DARPA, Arlington, VA.
>>
>> "Health Effects of Service in the Gulf War". Briefing to Advisory
>> Board of the National Defense Research Institute, (with Dr. Ross
>> Anthony). May 5, 1998, RAND, Santa Monica.
>>
>> "Health Effects of Service in the Gulf War". Briefing to RAND Board of
>> Trustees (with Dr. Ross Anthony), RAND's 50th birthday. April 9, 1998,
>> Washington, DC
>>
>> "Pyridostigmine bromide and illness in Persian Gulf War veterans".
>> Briefing to representatives from DoD, VA, FDA, PAC, and Congress. RAND
>> Washington, Nov 4, 1997, Washington DC.
>>
>> "Pyridostigmine bromide". Briefing to Israeli Defense and Health
>> personnel, as part of a mission to the Middle East with Dr. Bernard
>> Rostker (Assistant Secretary of the Navy; now Undersecretary of the
>> Army) and others from the DoD, Nov 1 1997, Tel Aviv, Israel;
>> participated in other briefings in the Middle East (Kuwait, Saudi
>> Arabia, and Egypt) during a ~2 week trip.
>>
>> Back to Top
>>
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> MEDIA RECOGNITION AND ATTENTION
>>
>> MEDIA RECOGNITION OF WORK
>>
>> National media recognition related to:
>>
>> 1.. Neural networks (CNN, popular book, 1990).
>> 2.. Cholesterol and violence (KNBC TV 11-97; NY Times 5 column
>> article,
>> CNN, NBC, ABC, CBS, LA Times, Reuters/AP, other 3-98).
>> 3.. Alcohol and diabetes (Fox News, Science News, 7-99); and
>> 4.. Pyridostigmine bromide and illness in Gulf War veterans (front
>> page
>> article on NY Times and LA Times; multiple other newspapers; NPR,
>> other radio stations, national TV news on ABC and CBS (lead story),
>> NBC; CNN, CSPAN; websites including policy.com, lead news story on
>> Yahoo, comedycentral.com; science journals including New Scientist)
>> International:
>>
>> 1.. For cholesterol and violence work, British newspapers;
>> 2.. For pyridostigmine bromide work: BBC radio interview, TV news
>> throughout Western Europe, Eastern Europe, Britain, Australia,
>> newspapers and news magazines throughout same distribution.
>>
>> -----------------------------------------------------------------------
>> ---------
>>
>> MEDIA ATTENTION
>>
>> 1.. Neural Networks/ facial expression:
>>
>> a.. CNN News 1990
>>
>>
>> 2.. Neural Networks/ gender recognition ("SexNet"):
>> a.. Book on Neural Network revolution
>>
>>
>> 3.. Cholesterol and Violence:
>> a.. KNBC TV News promo story) aired Nov 4 (Los Angeles) and Nov 5
>> (San
>> Diego), 1997
>>
>>
>> 4.. Cholesterol and Violence: re paper in Annals of Internal
>> Medicine:
>> a.. New York Times: "Researcher links reduction in cholesterol
>> with
>> violent death" (Denise Grady), Science section, B13 (5 column
>> article), March 17, 1998
>>
>> b.. CNN TV News, March 14, 1998
>>
>> c.. NBC News, radio interview, March 14, 1998
>> d.. ABC News, radio interview, March 14, 1998
>> e.. CBS News, radio interview, March 14, 1998
>> f.. Los Angeles Times; US News and World Report; (Reuters, AP)
>> other,
>> March 15, 1998
>> g.. Other (1998): Hippocrates, Men's Health, Clinical Pearls,
>> Internal
>> Medicine News, British publications
>>
>>
>> 5.. Alcohol consumption in diabetes editorial:
>> a.. Fox News, July 1999
>> b.. Science News, July 1999
>> c.. Channel 8 TV (interview with M Criqui), July 1999
>>
>>
>> 6.. Pyridostigmine bromide (PB) and illness in Gulf War veterans:
>> Pentagon Press Briefing and surrounding interviews
>> a.. New York Times, front page story: Oct 19, 1999
>> b.. Los Angeles Times, front page story: Oct 19, 1999
>> c.. Washington Post New York Times, front page story: Oct 19, 1999
>> d.. San Diego Union Tribune: Oct 20, 1999
>> e.. Multiple other newspapers
>> f.. New Scientist (science periodical)
>>
>> g.. CBS national television, Lead news story, Oct 19, 1999
>> h.. ABC national television, Lead news story, Oct 19, 1999
>> i.. NBC national television news, Oct 19, 1999
>> j.. CSPAN live and in replay, Oct 19 and 20, 1999
>> k.. San Diego, 3 local television news stations, Oct 19, 1999
>> l.. PBS radio interview: Oct 19, 1999
>> m.. BBC radio interview: Oct 19, 1999
>> n.. CNN live interview: Oct 20, 1999
>> o.. Several other local radio interviews: Oct 18 and 19, 1999
>> p.. Yahoo, Lead news story, Oct 20, 1999
>> q.. Daily Show, Comedy Central, Oct 1999 (TV show and website)
>> r.. Policy.com, Oct 1999
>> s.. International coverage: TV, newspapers, and news magazines
>> throughout Europe (e.g. England, Germany, Hungary)
>>
>>
>> 7.. Pyridostigmine bromide (PB) and illness in Gulf War veterans:
>> Congressional Testimony
>> a.. CSPAN live and replay, Nov 16 and Nov 20, 1999
>>
>>
>> 8.. Commentary on others' Gulf War work:
>> a.. NBC News (local, channel 7/39, 11-30-99)
>> b.. NPR radio,12-7-99)
>>
>> "Don Kirkman" <donkirk@covad.net> wrote in message
>> news:773jt0do1k3qm61ifff8q9elvcohlca7jj@4ax.com...
>>> It seems to me I heard somewhere that Sharon Hope wrote in article
>>> <Rp3Cd.742898$mD.174164@attbi_s02>:
>>>
>>>>The 15% is a measurement of fact.
>>>
>>> The issue is what is being measured. What is being measured is not
>>> the general population of cardiac patients nor the general population
>>> of statin users. What is being measured is Dr. Golomb's caseload,
>>> which is almost certainly not typical of most statin users because,
>>> first, she is in a university setting with patients who to some
>>> extent are self-selected and in general would be expected to be more
>>> serious cases and, second, who may have sought her out because of her
>>> interest in statin effects. The bulk of statin users are unlikely to
>>> be seeing a doctor at a university or VA clinic.
>>> --
>>> Don
>>> "I do not feel obliged to believe that the same God who has endowed
>>> us with senses, reason, and intellect has intended us to forgo their
>>> use. --Galileo Galilei
>>
>>
>>
>
- Next message: Sharon Hope: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Previous message: Sharon Hope: "Re: FDA: 139,000 people had heart attacks that may be linked to Vioxx"
- In reply to: listener: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Next in thread: Don Kirkman: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Messages sorted by: [ date ] [ thread ]
Relevant Pages
|
